FDA Opts To Fast Track Constipation Drug
Trying to accelerate the regulatory review process, the U.S. Food and Drug Administration has decided to fast-track Wyeth Pharmaceuticals and Progenics Pharmaceuticals' application for a drug intended to treat postoperative gastrointestinal...To view the full article, register now.
Already a subscriber? Click here to view full article